Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated results from the BERENICE study Meeting Abstract
| Authors: | Dang, C.; Ewer, M. S.; Delaloge, S.; Ferrero, J. M.; Verrill, M.; Colomer, R.; Vieira, C.; de la Cruz Merino, L.; Lucas, J.; Werner, T. L.; Douthwaite, H.; Bradley, D.; Waldron-Lynch, M.; Eng-Wong, J.; Swain, S. M. |
| Abstract Title: | Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated results from the BERENICE study |
| Meeting Title: | 40th Annual San Antonio Breast Cancer Symposium (SABCS 2017) |
| Journal Title: | Cancer Research |
| Volume: | 78 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2017 Dec 5-9 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2018-02-01 |
| Language: | English |
| ACCESSION: | WOS:000425489402021 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.SABCS17-P5-20-04 |
| Notes: | Meeting Abstract: P5-20-04 -- Source: Wos |
